Heirloom Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-211,886
Closed -$10.8M 90
2025
Q4
$10.8M Buy
211,886
+73,171
+53% +$3.74M 2.49% 16
2025
Q3
$7.7M Buy
138,715
+55,618
+67% +$3.26M 1.86% 21
2025
Q2
$5.74M Buy
83,097
+233
+0.3% +$15.8K 1.51% 22
2025
Q1
$5.75M Buy
82,864
+2,716
+3% +$224K 1.65% 20
2024
Q4
$6.89M Buy
80,148
+5,538
+7% +$599K 2.07% 16
2024
Q3
$8.88M Buy
74,610
+1,325
+2% +$177K 2.77% 13
2024
Q2
$10.5M Sell
73,285
-758
-1% -$100K 3.39% 11
2024
Q1
$9.51M Sell
74,043
-1,907
-3% -$227K 3.24% 11
2023
Q4
$7.86M Buy
75,950
+1,416
+2% +$140K 3.02% 11
2023
Q3
$6.78M Sell
74,534
-1,970
-3% -$174K 3.01% 11
2023
Q2
$6.19M Buy
76,504
+2,650
+4% +$216K 2.69% 14
2023
Q1
$5.88M Buy
73,854
+21,202
+40% +$1.5M 2.81% 14
2022
Q4
$3.56M Buy
+52,652
New +$3.09M 2.22% 17
2022
Q2
$3.74M Buy
71,518
+7,268
+11% +$403K 3.06% 15
2022
Q1
$3.41M Buy
+64,250
New +$3.3M 2.37% 16

Other funds holding NVO

Heirloom Wealth Management's NVO Position: Q1 2026 in Review

Heirloom Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 211,886 shares — an estimated $10.8M sold.

Heirloom Wealth Management first reported a position in NVO in Q1 2022 and held it in 15 quarters. The position peaked at $10.8M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Heirloom Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Heirloom Wealth Management sold 211,886 Novo Nordisk shares in Q1 2026, an estimated $10.8M.
  • Heirloom Wealth Management first reported a position in Novo Nordisk in Q1 2022 and held it in 15 quarters.
  • Heirloom Wealth Management's Novo Nordisk position peaked at $10.8M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Heirloom Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.